Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Moodys
Deloitte
Citi
Merck
Chubb
Federal Trade Commission
Cipla
Mallinckrodt
Farmers Insurance

Generated: September 21, 2018

DrugPatentWatch Database Preview

BUCLADIN-S Drug Profile

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

When do Bucladin-s patents expire, and what generic alternatives are available?

Bucladin-s is a drug marketed by Stuart Pharms and is included in one NDA.

The generic ingredient in BUCLADIN-S is buclizine hydrochloride. There is one drug master file entry for this compound. Additional details are available on the buclizine hydrochloride profile page.

Summary for BUCLADIN-S
US Patents:0
Applicants:1
NDAs:1
Bulk Api Vendors: 50
Patent Applications: 120
DailyMed Link:BUCLADIN-S at DailyMed
Drug patent expirations by year for BUCLADIN-S
Synonyms for BUCLADIN-S
(rs)-1-(4-t-butylbenzyl)-4-(4-chlorobenzhydryl) piperazine dihydrochloride
1-(4-(tert-Butyl)benzyl)-4-((4-chlorophenyl)-(phenyl)methyl)piperazine dihydrochloride
1-(4-(tert-Butyl)benzyl)-4-((4-chlorophenyl)(phenyl)methyl)piperazine dihydrochloride
1-(4-tert-butylbenzyl)-4-[(4-chlorophenyl)(phenyl)methyl]piperazine dihydrochloride
1-(4-tert-butylbenzyl)-4-[(4-chlorophenyl)(phenyl)methyl]piperazinediium dichloride
1-(p-Chlorobenzhydryl)-4-(p-t-butylbenzyl)diethylenediamine dihydrochloride
1-(p-chlorobenzhydryl)-4-(p-t-butylbenzyl)diethylenediaminedihydrochloride
1-(p-tert-butylbenzyl)-4-(p-chloro-alpha-phenylbenzyl)-piperazindihydrochl
1-(p-tert-Butylbenzyl)-4-(p-chloro-alpha-phenylbenzyl)piperazine dihydrochloride
1-(p-tert-Butylbenzyl)-4-(p-chlorodiphenylmethyl)piperazine dihydrochloride
1-[(4-tert-butylphenyl)methyl]-4-[(4-chlorophenyl)-phenylmethyl]piperazine dihydrochloride
1-[(4-tert-butylphenyl)methyl]-4-[(4-chlorophenyl)-phenylmethyl]piperazine;dihydrochloride
1-p-Chlorobenzhydryl-4-p-(t)-butylbenzylpiperazine dihydrochloride
129-74-8
129B748
163837-35-2
163837-36-3
4CA-0326
82-95-1 (Parent)
A 7668
AC1L23AJ
AK-54927
AKOS016004771
ANW-66382
Aphilan R
API0001773
AX8118925
BCP0726000050
BCP9000459
Bucladin S
Buclina
buclizine 2HCl
Buclizine dihydrochloride
Buclizine dihydrochloride, >=98% (HPLC)
Buclizine HCl
Buclizine hydrochloride
Buclizine hydrochloride (USAN)
Buclizine hydrochloride [USAN]
Buclizine hydrochloride, (-)-
Buclizine hydrochloride, (+)-
BUCLIZINE, DIHYDROCHLORIDE
C28H33ClN2
C28H33ClN2.2HCl
CAS-129-74-8
CHEBI:61193
CHEMBL2360580
CTK8C1377
D02089
DSSTox_CID_25091
DSSTox_GSID_45091
DSSTox_RID_80665
DTXSID5045091
EINECS 204-962-4
EOP5593FPH
FT-0663892
Histabutyzine dihydrochloride
Histabutyzine hydrochloride
J-005711
KB-214128
KS-00000FU4
KS-1250
Longifene
LS-110573
MFCD00242700
MolPort-006-110-855
NCGC00013315-01
NSC 25141
Perlapine, >=98% (HPLC)
Piperazine, 1-((4-chlorophenyl)phenylmethyl)-4-((4-(1,1-dimethylethyl)phenyl)methyl)-, dihydrochloride
Piperazine, 1-((4-chlorophenyl)phenylmethyl)-4-((4-(1,1-dimethylethyl)phenyl)methyl)-, dihydrochloride, (-)-
Piperazine, 1-((4-chlorophenyl)phenylmethyl)-4-((4-(1,1-dimethylethyl)phenyl)methyl)-, dihydrochloride, (+)-
Piperazine, 1-((4-chlorophenyl)phenylmethyl)-4-((4-(1,1-dimethylethyl)phenyl)methyl)-, hydrochloride (1:2)
Piperazine, 1-(p-tert-butylbenzyl)-4-(p-chloro-alpha-phenylbenzyl)-, dihydrochloride
Postafeno
Q710
s4140
SCHEMBL123751
Softran
ST24037299
TC-155127
Tox21_110023
UCB 4445
UCB-4445
UNII-EOP5593FPH
UNII-V4OCE982YU
V4OCE982YU
Vibazine (TN)
Vibazine hydrochloride

US Patents and Regulatory Information for BUCLADIN-S

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Stuart Pharms BUCLADIN-S buclizine hydrochloride TABLET;ORAL 010911-006 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

see a sample report or, see our see our flat-rate plans

see a sample report or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Moodys
Deloitte
Citi
Merck
Chubb
Federal Trade Commission
Cipla
Mallinckrodt
Farmers Insurance

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.